These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1198 related items for PubMed ID: 15982389

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma.
    Leong C, Boyages J, Jayasinghe UW, Bilous M, Ung O, Chua B, Salisbury E, Wong AY.
    Cancer; 2004 May 01; 100(9):1823-32. PubMed ID: 15112262
    [Abstract] [Full Text] [Related]

  • 4. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study.
    Benitez PR, Streeter O, Vicini F, Mehta V, Quiet C, Kuske R, Hayes MK, Arthur D, Kuerer H, Freedman G, Keisch M, Dipetrillo T, Khan D, Hudes R.
    Am J Surg; 2006 Oct 01; 192(4):427-33. PubMed ID: 16978943
    [Abstract] [Full Text] [Related]

  • 5. Ductal carcinoma in situ of the breast with close or focally involved margins following breast-conserving surgery: treatment with reexcision or radiotherapy with increased dosage.
    Monteau A, Sigal-Zafrani B, Kirova YM, Fourchotte V, Bollet MA, Vincent-Salomon A, Asselain B, Salmon RJ, Fourquet A.
    Int J Radiat Oncol Biol Phys; 2009 Nov 15; 75(4):1021-8. PubMed ID: 19386441
    [Abstract] [Full Text] [Related]

  • 6. Predictors of local recurrence following excision alone for ductal carcinoma in situ.
    Hetelekidis S, Collins L, Silver B, Manola J, Gelman R, Cooper A, Lester S, Lyons JA, Harris JR, Schnitt SJ.
    Cancer; 1999 Jan 15; 85(2):427-31. PubMed ID: 10023711
    [Abstract] [Full Text] [Related]

  • 7. Ductal carcinoma in situ. The success of breast conservation therapy: a shared experience of two single institutional nonrandomized prospective studies.
    Lagios MD, Silverstein MJ.
    Surg Oncol Clin N Am; 1997 Apr 15; 6(2):385-92. PubMed ID: 9115503
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Defining the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: a pathologic analysis.
    Vicini FA, Kestin LL, Goldstein NS.
    Int J Radiat Oncol Biol Phys; 2004 Nov 01; 60(3):722-30. PubMed ID: 15465188
    [Abstract] [Full Text] [Related]

  • 10. Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ: Possible importance of family history.
    Hiramatsu H, Bornstein BA, Recht A, Schnitt SJ, Baum JK, Connolly JL, Duda RB, Guidi AJ, Kaelin CM, Silver EB, Harris JR.
    Cancer J Sci Am; 1995 Nov 01; 1(1):55-61. PubMed ID: 9166455
    [Abstract] [Full Text] [Related]

  • 11. Ductal carcinoma in situ: size and resection volume predict margin status.
    Melstrom LG, Melstrom KA, Wang EC, Pilewskie M, Winchester DJ.
    Am J Clin Oncol; 2010 Oct 01; 33(5):438-42. PubMed ID: 20023569
    [Abstract] [Full Text] [Related]

  • 12. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study.
    Reitsamer R, Peintinger F, Kopp M, Menzel C, Kogelnik HD, Sedlmayer F.
    Strahlenther Onkol; 2004 Jan 01; 180(1):38-44. PubMed ID: 14704843
    [Abstract] [Full Text] [Related]

  • 13. The role of reexcision for positive margins in optimizing local disease control after breast-conserving surgery for cancer.
    Aziz D, Rawlinson E, Narod SA, Sun P, Lickley HL, McCready DR, Holloway CM.
    Breast J; 2006 Jan 01; 12(4):331-7. PubMed ID: 16848842
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The impact of lobular carcinoma in situ in association with invasive breast cancer on the rate of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy.
    Jolly S, Kestin LL, Goldstein NS, Vicini FA.
    Int J Radiat Oncol Biol Phys; 2006 Oct 01; 66(2):365-71. PubMed ID: 16965988
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ductal carcinoma in situ--the influence of the radiotherapy boost on local control.
    Wong P, Lambert C, Agnihotram RV, David M, Duclos M, Freeman CR.
    Int J Radiat Oncol Biol Phys; 2012 Feb 01; 82(2):e153-8. PubMed ID: 21664063
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma.
    Pawlik TM, Perry A, Strom EA, Babiera GV, Buchholz TA, Singletary E, Perkins GH, Ross MI, Schecter NR, Meric-Bernstam F, Ames FC, Hunt KK, Kuerer HM.
    Cancer; 2004 Feb 01; 100(3):490-8. PubMed ID: 14745864
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 60.